American Capital Advisory’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
Other funds holding ZBH
American Capital Advisory's ZBH Position: Q2 2026 in Review
American Capital Advisory reduced its Zimmer Biomet (ZBH) stake by 62% in Q2 2026, selling an estimated $701 and leaving 5 shares worth $431. The position accounts for ﹤0.01% of the portfolio, ranked #984.
American Capital Advisory first reported a position in ZBH in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.18K in Q1 2026. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- American Capital Advisory held 5 shares of Zimmer Biomet worth $431 as of Q2 2026.
- American Capital Advisory sold 8 Zimmer Biomet shares in Q2 2026, an estimated $701.
- Zimmer Biomet made up ﹤0.01% of American Capital Advisory's portfolio in Q2 2026, its #984 holding.
- American Capital Advisory first reported a position in Zimmer Biomet in Q1 2025 and has held it in 6 quarters since.
- American Capital Advisory's Zimmer Biomet position peaked at $1.18K in Q1 2026.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.